LIGAND PHARMACEUTICALS INC LGND
LIGAND PHARMACEUTICALS INC institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 2,871,496 | $242.0M | 14.15% |
| D. E. Shaw & Co., Inc. | 67,515 | $21.3M | 0.33% |
| TWO SIGMA INVESTMENTS, LP | 18,825 | $6.0M | 0.09% |
| CITADEL ADVISORS LLC | 11,700 | $3.7M | 0.06% |
| AQR CAPITAL MANAGEMENT LLC | 10,444 | $3.3M | 0.05% |
| MILLENNIUM MANAGEMENT LLC | 3,975 | $1.3M | 0.02% |
| Point72 Asset Management, L.P. | 800 | $252,872 | — |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.